About

Aaron Richman, MD is an Assistant Professor of Surgery at Boston University Chobanian & Avedisian School of Medicine. He received his medical degree from the University of California, San Diego, and completed a residency in General Surgery at Chobanian & Avedisian School of Medicine. Additionally, he completed a fellowship in Surgical Critical Care and Trauma at the University of Colorado/Denver Health Medical Center. Dr. Richman is board certified by the American Board of Surgery. His research includes topics such as applicant selection processes in surgery, trauma patient outcomes related to blood transfusion, quality improvement initiatives in gastrostomy tube management, and the utility of imaging in elderly patients with ground-level falls. He has published multiple articles in peer-reviewed journals and is actively involved in surgical research and education.

Research topics

• Internal medicine
• Emergency medicine
• Anesthesia
• Medicine
• Surgery

Selected publications

• Implementation of a quality improvement initiative reduced adult inpatient gastrostomy tube dislodgements

  The American Journal of Surgery · 2025-07-16 · 1 citations

  articleSenior author
  PublisherDOI

• Chest Tubes

  Contemporary surgical clerkships · 2025-01-01

  book-chapterSenior author
  PublisherDOI

• Identifying trauma patients who benefit from whole blood transfusion: An effect decomposition analysis on patient survival

  Transfusion · 2025-07-27 · 2 citations

  article

  BACKGROUND: Although whole blood (WB) transfusion has gained attention as a potentially superior alternative to component therapy (CT) for patients experiencing severe traumatic hemorrhage, conflicting evidence leaves its optimal use unclear. METHODS: We conducted a retrospective review of adult trauma patients treated at civilian trauma centers participating in Trauma Quality Improvement Program (TQIP) from 2020 to 2021. All received either WB or CT within four hours of emergency department arrival. We assessed the effect of WB versus CT by examining key clinical parameters and performing an effect decomposition analysis. RESULTS: Of 34,476 patients, 9023 (29%) received WB, while 25,453 (71%) received CT alone. Across the entire cohort, there was no statistically significant difference in adjusted odds of 24-h mortality (aOR 0.85 [95% confidence interval (CI) 0.73-1.01], p = .052). However, patients presenting with hypotension showed lower unadjusted and adjusted odds of death when given WB, including those with systolic blood pressure (SBP) below 90 mmHg (aOR 0.72 [95% CI 0.55-0.96], p = .02) and 70 mmHg (aOR 0.64 [95% CI 0.45-0.91], p = .01). DISCUSSION: These findings suggest that the effectiveness of whole blood (WB) is influenced by several clinical characteristics. Arrival hypotension appears to play a key role, accounting for 13% of the mortality difference observed with WB versus CT. Future prospective trials are needed to define optimal patient selection and identify those most likely to benefit from WB in trauma resuscitation.

  PublisherDOI

• Can Preference Signaling Streamline the Applicant Selection Process?

  Journal of surgical education · 2025-08-23 · 1 citations

  article
  PublisherDOI

• Seeing is Believing – A Qualitative Study Exploring What Motivates Medical Students to Pursue a Career In General Surgery

  Journal of surgical education · 2024-06-20 · 2 citations

  article
  PublisherDOI

• Long-term outcomes of autologous vein bypass for repair of upper and lower extremity major arterial trauma

  Journal of Vascular Surgery · 2024-01-30 · 9 citations

  articleOpen access
  PublisherOA PDFDOI

• Utility of Torso Imaging for Elderly Patients Sustaining Ground-Level Falls

  Journal of Surgical Research · 2024-07-13 · 1 citations

  article
  PublisherDOI

• Timing of venous thromboembolism prophylaxis initiation and complications in polytrauma patients with high-risk bleeding orthopedic interventions: A nationwide analysis

  The Journal of Trauma: Injury, Infection, and Critical Care · 2024-03-29 · 8 citations

  articleOpen access

  INTRODUCTION: There are no clear recommendations for the perioperative timing and initiation of venous thromboembolism pharmacologic prophylaxis (VTEp) among polytrauma patients undergoing high-risk bleeding orthopedic operative intervention, leading to variations in VTEp administration. Our study examined the association between the timing of VTEp and VTE complications in polytrauma patients undergoing high-risk operative orthopedic interventions nationwide. METHODS: We performed a retrospective cohort study of trauma patients 18 years or older who underwent high-risk bleeding operative orthopedic interventions for pelvic, hip, and femur fractures within 24 hours of admission at American College of Surgeons-verified trauma centers using the 2019-2020 American College of Surgeons Trauma Quality Improvement Program databank. We excluded patients with a competing risk of nonorthopedic surgical bleeding. We assessed operative orthopedic polytrauma patients who received VTEp within 12 hours of orthopedic surgical intervention compared with VTEp received beyond 12 hours of intervention. The primary outcome assessed was overall VTE events. Secondary outcomes were orthopedic reinterventions within 72 hours after primary orthopedic surgery, deep venous thromboembolism, and pulmonary embolism rates. RESULTS: The study included 2,229 patients who underwent high-risk orthopedic operative intervention. The median time to VTEp initiation was 30 hours (interquartile range, 18-44 hours). After adjustment for baseline patient, injury, and hospital characteristics, VTEp initiated more than 12 hours from primary orthopedic surgery was associated with increased odds of VTE (adjusted odds ratio, 2.02; 95% confidence interval, 1.08-3.77). Earlier initiation of prophylaxis was not associated with an increased risk for surgical reintervention (hazard ratio, 0.90; 95% confidence interval, 0.62-1.34). CONCLUSION: Administering VTEp within 24 hours of admission and within 12 hours of major orthopedic surgery involving the femur, pelvis, or hip demonstrated an associated decreased risk of in-hospital VTE without an accompanying elevated risk of bleeding-related orthopedic reintervention. Clinicians should reconsider delays in initiating or withholding perioperative VTEp for stable polytrauma patients needing major orthopedic intervention. LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.

  PublisherOA PDFDOI

• Mining for Gold: A Mixed-Methods Study on Personal Statements in General Surgery Residency Applications

  Journal of Surgical Research · 2024-09-09 · 2 citations

  article
  PublisherDOI

• Long-term outcomes of autologous vein bypass for repair of upper and lower extremity major arterial trauma

  European Journal of Vascular and Endovascular Surgery · 2024-06-01

  articleOpen access
  PublisherOA PDFDOI

Frequent coauthors

• Christian A. Hamlat

  St. Luke's Clinic

  250 shared

• Ronald V. Maier

  University of Washington

  250 shared

• Sacha Zeerleder

  University of Lucerne

  242 shared

• Rui P. Moreno

  Imperial College London

  127 shared

• Michael A. Flierl

  State Library of Ohio

  127 shared

• Robert S. Green

  Dalhousie University

  127 shared

• Susan M. Lareau

  126 shared

• Thomas H. Cogbill

  Gundersen Health System

  126 shared

Education

• MD, School of Medicine

  University of California San Diego

  2012

• BS, Chemical Engineering

  University of Colorado Boulder

  2007